Heterogeneity of cell therapy products

Wolmarans, E; Mellet, J; Ambele, M. A; Durandt, C; Pepper, M. S

Wolmarans, E; Mellet, J; Ambele, M. A; Durandt, C; Pepper, M. S.

Afiliação

Wolmarans, E; s.af
Mellet, J; s.af
Ambele, M. A; s.af
Durandt, C; s.af
Pepper, M. S; s.af

S. Afr. med. j. (Online) ; 109(8): 25-29, 2019. ilus

Article em En | AIM | ID: biblio-1271225

Biblioteca responsável: CG1.1

ABSTRACT

ABSTRACT

Cellular therapy has become a billion-dollar industry and is set to become one of the therapeutic pillars of healthcare in the 21st century. Adult stem cells, which include haematopoietic stem and progenitor cells (HSPCs) and mesenchymal stromal/stem cells (MSCs), is one of the major cell types currently under investigation for use in cell therapy. This review focuses on HSPCs and MSCs and discusses their heterogeneous nature and the problems faced in expanding these cells to therapeutic numbers for use in clinical applications

Assuntos

Células; Produtos do Gene gag; Heterogeneidade Genética; Terapêutica

Buscar no Google

Imprimir

XML

Assunto principal: Terapêutica / Produtos do Gene gag / Células / Heterogeneidade Genética Idioma: En Revista: S. Afr. med. j. (Online) Ano de publicação: 2019 Tipo de documento: Article

Buscar no Google

Imprimir

XML